SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Total revenue for the quarter ended December 2023 of  Rs. 1328.30 millions remain, more or less, the same.The Company's Net profit for the December 2023 quarter have declined marginally to Rs. 554.50  millions as against Rs. 591.70 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 812.20 millions from 808.70 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1328.30 1306.00 1.71 4857.10 3839.40 26.51 5286.10 5280.60 0.10
Other Income 179.00 293.60 -39.03 696.60 867.80 -19.73 990.00 565.50 75.07
PBIDT 812.20 808.70 0.43 2990.50 2418.20 23.67 3189.20 2761.70 15.48
Interest 0.30 0.40 -25.00 0.80 0.90 -11.11 1.20 0.90 33.33
PBDT 811.90 808.30 0.45 2989.70 2417.30 23.68 3188.00 2760.80 15.47
Depreciation 67.60 64.70 4.48 201.50 193.50 4.13 256.50 257.70 -0.47
PBT 744.30 743.60 0.09 2788.20 2223.80 25.38 2931.50 2503.10 17.11
TAX 189.80 151.90 24.95 650.00 424.60 53.09 588.90 624.40 -5.69
Deferred Tax -9.30 -16.60 -43.98 -39.00 -61.70 -36.79 -76.90 8.20 -1037.80
PAT 554.50 591.70 -6.29 2138.20 1799.20 18.84 2342.60 1878.70 24.69
Equity 151.90 151.80 0.07 151.90 151.80 0.07 151.80 151.60 0.13
PBIDTM(%) 61.15 61.92 -1.25 61.57 62.98 -2.25 60.33 52.30 15.36

Caplin Point Labs. Share Price

2528.10 -34.05 (-1.33%)
02-Jul-2026 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1881.00
Dr. Reddys Labs. 1345.50
Cipla 1461.95
Zydus Lifesciences 1101.70
Lupin 2392.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: